- £745.11m
- £1.98bn
- £1.51bn
- 45
- 59
- 27
- 35
Annual income statement for Spire Healthcare, fiscal year end - December 31st, GBP millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 557 | 1,048 | 1,195 | 1,359 | 1,511 |
| Cost of Revenue | |||||
| Gross Profit | 93.1 | 433 | 535 | 624 | 684 |
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 703 | 961 | 1,103 | 1,233 | 1,374 |
| Operating Profit | -146 | 86.9 | 92.3 | 126 | 138 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -231 | -1.9 | 3.9 | 34.6 | 38.3 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -234 | -8.9 | 8.2 | 27.9 | 26 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | -234 | -9.7 | 8.6 | 27.3 | 25.4 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -234 | -9.7 | 8.6 | 27.3 | 25.4 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.459 | -0.091 | 0.042 | 0.076 | 0.089 |
| Dividends per Share |